Sector Focus

• Biotechnology
• Pharmaceutical
• Devices / Diagnostic / Other

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

• Adolor Corporation
• Advanced Tissue Sciences, Inc.
• Alpha Therapeutic Corporation (now Grifols)
• Applied Immune Sciences, Inc. (now Sanofi-Aventis)
• Armour Pharmaceutical Co. (now CSL Behring)
• Avalon Pharmaceuticals, Inc. (now Clinical Data Inc.)
• Bayer Healthcare Pharmaceuticals, Inc.
• BioChem Pharma, Inc.
• Cell Genesys, Inc.
• Cell Therapeutics, Inc.
• Centocor, Inc. (division of Johnson & Johnson)
• Cephalon, Inc.
• Ceregene, Inc.
• CFY BioMedicals, Inc. (later renamed Perlan Therapeutics)
• CIMA Labs, Inc. (now Cephalon)
• CoCensys, Inc. (now Purdue)
• Coley Pharmaceutical Group, Inc. (now Pfizer)
• Conforma Therapeutics Corporation (now Biogen Idec)
• Corixa Corporation (now GSK)
• Coulter Pharmaceuticals, Inc. (now GSK)
• Curagen Corporation
• Enchira Biotechnology Corporation
• Enzon, Inc.
• GenStar Therapeutics Corporation (now VIA Pharmaceuticals)
• Genzyme Corporation
• Immunization Products, Ltd.
• Isis Pharmaceuticals, Inc.
• Koronis Pharmaceuticals, Inc.
• MedImmune, Inc.
• Myriad Genetics, Inc.
• Paratek Pharmaceuticals, Inc.
• Pharmion Corporation (now Celgene)
• Repligen Corporation
• RPR-Gencell
• Salmedix, Inc. (now Cephalon)
• Schein Pharmaceuticals, Inc. (now Watson Laboratories)
• Selective Genetics, Inc.
• Sepracor, Inc.
• SGX Pharmaceuticals, Inc. (now Pfizer)
• SmithKline Beecham Corporation (now GlaxoSmithKline)
• Sonus Pharmaceuticals(now OncoGenex Pharmaceuticals)
• Sugen, Inc. (now Pfizer)
• VaxInnate Corporation
• Versicor, Inc. (now Pfizer)
• Vical, Inc.
• ViroPharma, Inc.
• Zeneca, Inc. (now AstraZeneca)

ViroPharma, Inc.

ViroPharma Incorporated is a multinational biotechnology company committed to developing and commercializing innovative products that address unmet medical needs. Their current focus is to develop products for physician specialists that support patients with serious diseases caused by CMV, C. difficile, and hereditary angioedema.

Search Projects

• Head, Commercial Manufacturing
• Project Leader